Nike and UnitedHealth lead the Dow higher as investors buy into defensive blue chips and step away from the market’s high-flying technology names, helping the index stage a 529-point rally even as broader sentiment stays shaky.
Nike, UnitedHealth Lead Dow Higher on Rotation
The move matters because it shows the market is still willing to rotate into large-cap, cash-generative companies when inflation, earnings risk and valuation pressure hit growth stocks. With the S&P 500 and Nasdaq under pressure from a renewed selloff in AI shares, the Dow’s strength stands out as a vote of confidence in old-economy and healthcare names rather than in the rally’s tech leaders.
Sentiment Indicators
Nike’s rebound is notable after a rough stretch that has left the stock well below its longer-term trend. At $37.13, the shares are still far under the 200-day moving average of $46.64, though recent gains have pulled the stock back toward its 50-day moving average around $37.40. The latest trading has also pushed the shares away from oversold territory, with RSI readings recovering to 55.7 from a deep low earlier in the year.
UnitedHealth has been doing the heavy lifting on the other side of the ledger. The stock closed at $401.43, well above its 50-day moving average of $386.09 and near the upper end of its recent trading range, after a sharp recovery from the spring selloff. Its RSI at 65.2 suggests momentum remains constructive, and the stock’s strength has helped offset weakness elsewhere in the index.
For investors, the message is less about a single day’s point gain than about where money is hiding. Dow components tied to healthcare and consumer brands are attracting demand while traders trim exposure to higher-multiple technology shares that have become more vulnerable to macro shocks, including inflation readings and interest-rate uncertainty.
That rotation keeps the market in a defensive posture heading into earnings season. If inflation stays sticky and AI-linked stocks remain volatile, the Dow’s relative resilience could continue to draw attention from investors looking for steadier earnings, dividends and less valuation risk.
| Entity | Gains | Losses |
|---|---|---|
| Nike | ▲Rebound in a beaten-down stock | ▼Still below 200-day moving average |
| UnitedHealth | ▲Defensive buying and momentum | ▼Elevated scrutiny after sharp run |
| Dow components | ▲Support from healthcare and consumer names | ▼Less participation from tech leaders |
| AI stocks | ▲— | ▼Pressure from valuation and macro concerns |
